International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL);Internationales, prospektives register zur erfassung der initial- und dauertherapie von patienten mit pulmonaler hypertonie (CompERA-XL)

Deutsche Medizinische Wochenschrift

Volumn 134, Issue SUPPL. 5, 2009, Pages

  Pittrow, D ^a   Ghofrani, H A ^b   Opitz, C F ^c   Huscher, D ^d   Hoeper, M M ^e  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c German Red Cross Hospital   (Germany)

^d DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Combination therapy; Health care research; Pulmonary hypertension

Indexed keywords

DISEASE REGISTRY; DOCUMENTATION; HUMAN; INTERNET; MAINTENANCE THERAPY; PRACTICE GUIDELINE; PULMONARY HYPERTENSION; QUALITY CONTROL; REVIEW; CLASSIFICATION; DRUG ANTAGONISM; ETHICS; EUROPE; HEALTH CARE QUALITY; PROFESSIONAL STANDARD; REGISTER; STANDARD; TREATMENT OUTCOME;

ENDOTHELIN RECEPTOR;

ETHICS COMMITTEES; EUROPE; HUMANS; HYPERTENSION, PULMONARY; INTERNET; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; RECEPTORS, ENDOTHELIN; REGISTRIES; TREATMENT OUTCOME;

EID: 70349336309     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1225318     Document Type: Review

References (17)

1. Alpert JS. Are data from clinical registries of any value? Eur Heart J 2000; 21: 1399-1401
2. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008; 31: 1357-1367
3. Blin P, Bouillon K, Abenhaim L, Galié N. Thelin Outcomes for Patient Surveillance (TOPS): post-marketing surveillance of sitaxentan in patients with pulmonary arterial hypertension. Präsentation bei Annual Meeting der ESC 2008 [Abstract 85291]. http://spo.escardio.org/eslides/view. aspx?eevtid=24&id=3516 (Zugriff am 20.6.2009)
4. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008 32 1371-1385
5. Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51: 1527-1538
6. Dupuis J, Hoeper MM. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008; 31: 407-415
7. European Society of Cardiology. Registries, Databases, Protocols and Surveys. Internet: http://www.escardio.org/knowledge/ehs/registries/. (Zugriff am 20.6. 2009)
8. Ewert R, Opitz CF, Schaper C, Glaser S. Medikamentöse Kombinationsbehandlung bei Patienten mit Pulmonal arterieller Hypertonie. Dtsch Med Wochenschr 2008; 133 (Suppl 6): S187-901
9. Galiè N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009; 30: 394-403
10. Gomberg-Maitland M, Olschewski H. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008; 31: 891-901
11. Hoeper MM, Markevych I, Spiekerkoetter E, Welte T, Niedermeyer J. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J 2005; 26: 858-863 (Pubitemid 41632043)
12. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: 2011-2020
13. Hoeper MM, Oudiz RJ, Peacock A et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 2004; 43 (12 Suppl S): 48S-55S
14. Humbert M, Segal ES, Kiely DG, Carlsen J, Schwierin B, Hoeper MM. Results of European post-marketing surveillance of bosentan in pulmonary hypertension. Eur Respir J 2007; 30: 338-344
15. Verband der forschenden Arzneimittelhersteller (VfA). Orphan-Arzneimittel nach Indikationen (Stand: März 2007) Internet: http:// www.vfa.de/de/forschung/am-entwicklung/orphan-drugs-list/. (Zugriff am 20.6.2009)
16. VOLT. An Observational Study For Ambrisentan. Informationen unter: http://clinicaltrials.gov/ct2/show/NCT00679224 (Zugriff am 20.6.2009)
17. Wilkens H, Bauer M, Forestier N et al. Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension. Circulation 2003; 107: 1509-1513